# OnCo record tar-200 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tar-200/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tar-200" ;
  schema:name "Gemcitabine intravesical system (TAR-200)"@en ;
  schema:description "TAR-200 is a small pretzel-shaped device placed in the bladder that releases gemcitabine for three weeks at a time. It was approved in 2025 for early bladder cancer that no longer responds to BCG."@en ;
  schema:url <https://onco.cc/drugs/tar-200/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04640623> ;
  onco:status "approved" ;
  onco:modality "Intravesical drug-eluting device" ;
  schema:alternateName "Inlexzo" ;
  onco:approval "US 2025: BCG-unresponsive high-risk NMIBC with CIS, with or without papillary tumours" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/non-muscle-invasive-bladder-cancer/> ;
  onco:technologies <https://onco.cc/technologies/bcg-and-intravesical-therapy/> ;
  onco:companies <https://onco.cc/companies/johnson-johnson/> ;
  onco:terms <https://onco.cc/terms/bcg-unresponsive/> ;
  onco:trials <https://onco.cc/trials/sunrise-1/>, <https://onco.cc/trials/nct06211764/> .